Stavudine (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Stavudine drug offered from KAISER FOUNDATION HOSPITALS. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Stavudine |
SUBSTANCE NAME: | STAVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-01-27 |
END MARKETING DATE: | 0000-00-00 |
Stavudine HUMAN PRESCRIPTION DRUG Details:
Item Description | Stavudine from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2010-01-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0028_0c80436e-c57d-4cf7-afb4-a3d70e4fb5d4 |
PRODUCT NDC: | 0179-0028 |
APPLICATION NUMBER: | ANDA078957 |
Other STAVUDINE Pharmaceutical Manufacturers / Labelers: